Capstone Therapeutics Corp. – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 06/30/19 Q2

ended 03/31/19 Q1

ended 12/31/18 FY 2018

ended 09/30/18 Q3

ended 06/30/18 Q2

Prospectuses and Registrations Filter

Securities registration termination

Going private transaction – amended

Going private transaction – amended

Going private transaction

Amendment to registration of securities for employees

Ownership Filter

BP Peptides, LLC

BP Peptides, LLC

Alimco Financial Corp

Alimco Financial Corp

News Filter

Material Definitive Agreement, Material Modification to Rights of Security Holders, Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Shareholder Vote Results, Financial Statements or Exhibits

Material Definitive Agreement, New Financial Obligation or Off-Balance Sheet Arrangement, Financial Statements or Exhibits

LipimetiX Development Announces Sub-License of Apo E Mimetic Peptide Platform to Anji Pharma, China

Material Definitive Agreement, New Financial Obligation or Off-Balance Sheet Arrangement, Financial Statements or Exhibits

Change in Certifying Accountant

Proxies Filter

Definitive proxy

Preliminary revised proxy

Preliminary proxy

Definitive proxy

Preliminary proxy

Other Filter

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC